| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/15/2007 | US20070060543 Aminated complex-type sugar chain derivatives and process for the production thereof |
| 03/15/2007 | US20070060538 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/15/2007 | US20070060535 Targeted delivery of antiviral compounds through hemoglobin bioconjugates |
| 03/15/2007 | US20070060513 Method for increasing the serum half-life of a biologically active molecule |
| 03/15/2007 | US20070060508 Binding molecules |
| 03/15/2007 | US20070060497 Reagents for modifying biopharmaceuticals, the use and production thereof |
| 03/15/2007 | US20070059828 Carrier for nucleic acid molecule delivery |
| 03/15/2007 | US20070059806 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection |
| 03/15/2007 | US20070059799 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions |
| 03/15/2007 | US20070059729 Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer |
| 03/15/2007 | US20070059681 Method for production of bioresorable microparticles, microparticles thus obtained and use thereof |
| 03/15/2007 | US20070059547 Process for preparation of inclusion compounds between a non-steroidal anti-inflammatory drug and betacyclodextrin by microwave treatment |
| 03/15/2007 | US20070059376 Peptide conjugate |
| 03/15/2007 | US20070059363 Continuously introducing the mixed fluids into a dryer from the two or more different fluids for preparation of sustained release microspheres containing a biodegradable polymer, a drug, an additive and a solvent with different types of contents or both of the components, by controlling the mixing ratios |
| 03/15/2007 | US20070059358 Matrix adjuvants and the drop pills prepared with them |
| 03/15/2007 | US20070059353 Polyarginine-modified liposome having nuclear entry ability |
| 03/15/2007 | US20070059341 Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy |
| 03/15/2007 | US20070059340 Omega-3 Fatty Acids Encapsulated In Zein Coatings and Food Products Incorporating the Same |
| 03/15/2007 | US20070059339 Nutraceutical; aqueous extract of Sibiraea leaves; obesity, lipid metabolism, hypoglycemic agent, hair growth, healthy food |
| 03/15/2007 | US20070059338 Compositions and techniques for localized therapy |
| 03/15/2007 | US20070059328 Process for manufacturing pharmaceutical composition comprises of mycobacterium w in the treatment of asthma (obstructive lung disease) |
| 03/15/2007 | US20070059298 Method for administering a vaginal care composition |
| 03/15/2007 | US20070059285 Human serum albumin-free stabilized interferon liquid formulations |
| 03/15/2007 | US20070059275 Antibody toxin conjugates |
| 03/15/2007 | US20070059271 polyethylene glycol/poly( beta -benzyl-L-aspartate)-ac block copolymer; useful as carrier for in vivo delivery of active substances such as DNA; enables provision of PIC micelles having higher gene transfer effectivity |
| 03/15/2007 | US20070059253 drug delivery; skin disorders; supplying corticosteroid and fungicides |
| 03/15/2007 | US20070059252 follicle stimulating hormone (FSH) and luteinising hormone (LH); surfactant such as polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monopalmitate, and polyoxyethylene sorbitan monooleate, and stabilizer and tonicity agent such as monosaccharides, disaccharides and sugar alcohols |
| 03/15/2007 | CA2621800A1 Fine particles of poorly soluble drug having enteric base material adsorbed on the surface thereof |
| 03/15/2007 | CA2621774A1 A medical composition for treating wounds |
| 03/15/2007 | CA2621604A1 Bi-modal hyaluronate solution |
| 03/15/2007 | CA2621395A1 Biodegradable microparticle pharmaceutical formulations exhibiting improved release rates |
| 03/15/2007 | CA2621055A1 Sustained-release microsphere containing short chain deoxyribonucleic acid or short chain ribonucleic acid and method of producing the same |
| 03/15/2007 | CA2620132A1 Lactoferrin complex and method of producing the same |
| 03/14/2007 | EP1762574A2 Chemical modification of proteins to improve biocompatibility and bioactivity |
| 03/14/2007 | EP1762250A1 Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine |
| 03/14/2007 | EP1762249A2 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 03/14/2007 | EP1762235A1 Orally adminstered composition for preventing neonatal hemorrhages, in a tardy form, caused by a K-vitamin deficiency |
| 03/14/2007 | EP1761560A1 Peptide-based compounds |
| 03/14/2007 | EP1761283A2 Biodegradable drug-polymer delivery system |
| 03/14/2007 | EP1761282A2 Preparation of macromolecular conjugates by four-component condensation reaction |
| 03/14/2007 | EP1761265A2 A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device |
| 03/14/2007 | EP1761261A1 Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| 03/14/2007 | EP1761252A1 Matrix-controlled transdermal therapeutic system based on an adhesive for administering norelgestromin or the combination thereof with an estrogen |
| 03/14/2007 | EP1761248A1 Carbohydrate-derivatized liposomes for targeting cellular carbohydrate recognition domains of ctl/ctld lectins, and intracellular delivery of therapeutically active compounds |
| 03/14/2007 | EP1761247A1 Injectable pharmaceutical suspension comprising posaconazole |
| 03/14/2007 | EP1694311A4 Chewable soft capsules containing ungelatinized starch |
| 03/14/2007 | EP1526839B1 Oral pharmaceutical forms of liquid drugs having improved bioavailability |
| 03/14/2007 | EP1502595B1 An injection made from ixeris sonchifolia for treatment of cardio-cerebral vascular disease and fundus diseases and method of producing thereof |
| 03/14/2007 | EP1467706B1 Dermal application system for aminolevulinic acid-derivatives |
| 03/14/2007 | EP1448235B1 Oral controlled release pharmaceutical compositions of 5,8,14-triazatetracyclo 10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene |
| 03/14/2007 | EP1427394B1 Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities |
| 03/14/2007 | EP1399152B1 Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid mono-ester |
| 03/14/2007 | EP1397156B1 Oral administration of parathyroid hormone and calcitonin |
| 03/14/2007 | EP1385502B1 Medicament comprising an anhydrous formulation of xanthogenate |
| 03/14/2007 | EP1372667A4 Compositions for delivering bisphosphonates |
| 03/14/2007 | EP1347764B1 Gel composition based on alcohol for the treatment of hypogonadism through transscrotal application |
| 03/14/2007 | EP1337276B1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 03/14/2007 | EP1259262B1 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 03/14/2007 | EP1216031B1 Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing |
| 03/14/2007 | EP1171101B1 Method for producing a water-insoluble amorphous controlled release matrix |
| 03/14/2007 | EP1133318B1 Supramolecular complexes containing therapeutic agents |
| 03/14/2007 | EP1098979B1 Antibody with improved producibility |
| 03/14/2007 | EP1041978B1 Methods of inactivating bacteria including bacterial spores |
| 03/14/2007 | EP1011637B1 Modulation of drug loading in multivesicular liposomes |
| 03/14/2007 | EP0981328B1 Composition forming an emulsion for a taxoid compound |
| 03/14/2007 | EP0944648B1 Glp-1 derivatives |
| 03/14/2007 | CN1930190A Hyaluronic acid derivative and drug containing the same |
| 03/14/2007 | CN1930149A Composition comprising an optically-active monomeric compound, method implementing said composition, monomeric compound, polymer comprising same, and use thereof |
| 03/14/2007 | CN1929868A Lyposome-containing x ray-imaging agent and method for producing the same |
| 03/14/2007 | CN1929866A Enzyme-prodrug therapy for prosthetic joint repair |
| 03/14/2007 | CN1929865A Conjugates of hydroxyalkyl starch and a protein |
| 03/14/2007 | CN1929864A Complex particles and coated complex particles |
| 03/14/2007 | CN1929860A Site-specific chemical modification of HIV gp41-derived peptides |
| 03/14/2007 | CN1929857A N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof |
| 03/14/2007 | CN1929847A Fasudil-containing preparation and method of improving stability thereof |
| 03/14/2007 | CN1929839A Controlled release pharmaceutical composition of tolperisone for oral administration |
| 03/14/2007 | CN1929838A Solid pharmaceutical preparation containing sparingly water-soluble drug |
| 03/14/2007 | CN1929827A Transdermal delivery device for dihydropyridine type calcium antagonists containing at least one fatty acid |
| 03/14/2007 | CN1929817A Microemulsion formulations comprising particular substance P antagonists |
| 03/14/2007 | CN1929816A Pharmaceutical compositions comprising midazolam in a high concentration |
| 03/14/2007 | CN1927913A Chemical preparation method of hollow polymer microsphere with controllable open pores |
| 03/14/2007 | CN1927906A Organism degradable star-type structure poly (glycolide-lactide) medicine carrier microsphere and preparation method thereof |
| 03/14/2007 | CN1927400A Biomagnetism nano target anti-cancer drug and its preparation |
| 03/14/2007 | CN1927370A Baofukang vaginal soft capsule and its preparing process |
| 03/14/2007 | CN1927240A Traditional Chinese medicine mask composition for depigmenting |
| 03/14/2007 | CN1927226A Cow sex-control sperm freezing preservation seminal fluid dilution |
| 03/14/2007 | CN1927222A Vanadium tonic comprising anion exchange resin as carrier, their preparation method and uses |
| 03/14/2007 | CN1927215A Nifuratel-nystatin vaginal gel and method for preparing same |
| 03/14/2007 | CN1927202A Vitamin E nicotinate microcapsule and its preparing process |
| 03/14/2007 | CN1927201A Antibiotic compound recipe comprising piperacillin |
| 03/14/2007 | CN1927200A Bilobalide self-tiny-emulsifying soft capsule and its preparing process |
| 03/14/2007 | CN1927195A Film agent comprising sodium gualenate using for eyes |
| 03/14/2007 | CN1927189A Percutaneous absorption-type pharmaceutical preparations |
| 03/14/2007 | CN1927188A Voltage endurance vitamin E microcapsule and its preparing process |
| 03/14/2007 | CN1927186A Formulation of plant source hard capsule case and preparing method thereof |
| 03/14/2007 | CN1927183A Antineoplasma medicine pidorubicin slow release microsphere preparation and method for preparing same |
| 03/14/2007 | CN1927180A Anticancer slow release injection comprising tetrazole violet and potentiating agent thereof |
| 03/14/2007 | CN1927179A Compound recipe anticancer slow release injection comprising tetrazole violet |
| 03/14/2007 | CN1927178A Slow release injection loading both tetrazole violet and cytotoxic drug |
| 03/14/2007 | CN1927177A Anticancer drug composition loading both platinum compound and tetrazole violet |